FDA has approved clinical trial for Tocilizumab to treat hospitalized patients with severe COVID-19 pneumonia
The FDA ( U.S. Food & Drug Administration ) has approved a randomized, double-blind, placebo-controlled phase III clinical trial in collaboration with BARDA ( Biomedical Advanced Research and Deve ...
read article